# Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-trastuzumab-deruxtecan-in-patients-with-her2-expressing/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Funda Meric‐Bernstam,Vicky Makker,Ana Oaknin,Do‐Youn Oh,Susana Banerjee,Antonio González-Martı́n,Kyung Hae Jung,Iwona Ługowska,Luís Manso,Aránzazu Manzano,Bohuslav Melichar,Salvatore Siena,Daniil Stroyakovskiy,Anitra Fielding,Yan Ma,Soham D. Puvvada,Norah J. Shire,Jung‐Yun Lee |
| Citations | 1,003 |
| DOI | 10.1200/jco.23.02005 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.23.02005 |
| OpenAlex ID | https://openalex.org/W4387865238 |
| PMID | 37870536 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Iwona Ługowska](https://scholariq.org/researchers/iwona-ugowska/)
- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.